Atlas Trials

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Clinical trial NCT05567796 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05567796
Sponsor
Novo Nordisk A/S
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Obesity
Start date
2022-11-01
Primary completion
2024-10-30
Enrollment
3400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.